brainmetsbc.org

Length of Survival for Different Types of Breast Cancer Brain Metastases

Also see HER2-positive and Triple Negative Brain Metastases

D. Rades et al  A Simple Survival Score for Patients with Brain Metastases from Breast Cancer  Staahlenter Onkol  2013 Aug;189(8):664-7

S. Chiou  Survival of Brain Metastatic Patients Treated with Gamma Knife Radiosurgery Alone Clin Neurol Neurosurg 2013 March 115(3):260-5

M. Tarhan et al  The Clinicopathological Evaluation of the Breast Cancer Patients with Brain Metastases: Predictors of Survival  Clin Exp Metasis 2013 Feb 30(2):201-213

C. Nieder et al  Brain Metastases in Patients Under 50 Years of Age: Retrospective Analysis  Clin Exp Metastasis 2012 Dec;29(8):949-956

A. Berghoff et al  Brain-Only Metastatic Breast Cancer is a Distinct Clinical Entity Characterised by Favourable Median Overall Survival Time and a High Rate of Long-Term Survivors  Br J Cancer 2012 Oct 23 107(9):1454-8

Q. Zhang et al Systemic Treatment After Whole-Brain Radiotherapy May Improve Survival in RPA class ll/lll Breast Cancer Patients with Brain Metastasis  J Neurooncol 2012 Sep 114(2):181-9

P. Sperduto et al   Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases  Korea   Journal of Clinical Oncology  Feb 1, 2012  vol 30 number 4

M. Tarhan et al   The Clinicopathologic evaluation of Breast cancer Patients with brain metastases: Predictors of Survival  Clin Exp Metastasis DOI 10.1007/s10585-012-9528-7

N. Marko et al   Predicting Survival in Women With Breast Cancer and Brain Metastasis   Cancer 20ll American Cancer Society  

H. Kim et al    Clinical Outcome of Central Nervous System Metastases from Breast Cancer: Differences in Survival Depending on Systemic Treatment   Journal Neuro  Oncology 2012 106:303-131

U. Arslan et al Breast Cancer Subtypes and Outcomes of Central Nervous System Metastases Breast Aug 24 2011

C. Anders et al The Prognostic Contribution of Clinical Breast Cancer Subtypes, Age and Race among Patients with Breast Cancer Metastases Cancer April 2011 117(8):1602-1

P. Sperduto et al Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients with Breast Cancer and Brain Metastases International Journal of Radiation Oncology Biology Physics Feb 11 2011

S. Dawood et al  Prognostic Factors of Survival in the Trastuzumab (Herceptin) era among Women with Breast Cancer and Brain Metastases who Receive Whole Brain Radiotherapy: a Single-Institution Review  Journal of Clinical Oncology Jan 1 2010 28(1)

C. Nieder et al  Prediction of Short Survival in Patients with Brain Metastases Based on Three Different Scores: A Role for  Triple-Negative Status?  Clin Oncol (R Coll Radio) Feb 2010 22(1):65-59

P. Feyer et al   DEGRO Practical Guidelines for Palliative Radiotherapy of Breast Cancer Patients: Brain Metastases and Leptomeningeal Carcinomatosis  Strahlenther Onkologie Feb 2010 186(2):63-9

A. Gonzalez-Angulo and G. Hortobagyi  Brain Metastases and Breast Cancer Subtypes  Onkologie Mar 19 2010 33(4):143-4

Z. Arik et al  Long-Term Survivors among Breast Cancer Patients with Brain Metastases  Annals of Oncology May 2010 21 (5):1128

Niwinska et al  Breast Cancer Brain Metastases: Differences in Survival Depending on Biological Subtype, RPA RTOG Prognostic Class and Systemic Treatment after Whole-Brain Radiotherapy (WBRT)  Annals of Oncology May 2010 21(5):942-8

P. Sperduto et al  Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients with Newly Diagnosed Brain Metastases: a Multi-institutional Analysis of 4,259 Patients  International Journal of Radiation Oncology and Physics  Jul 1 2010 77(3):655-61

S. Gripp et al  Palliative Radiotherapy Tailored to Life Expectancy in End-Stage Cancer Patients: Reality or Myth  Cancer Jul 1 2010 116(13):3251-6